Harnessing the preconditioning phenomenon: Does remote organ ischaemia provide the answer?

Heart

Volumn 92, Issue 10, 2006, Pages 1367-1368

  Burdess, A ^b   Newby, David E ^a,b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN;

CLINICAL PRACTICE; EDITORIAL; HEART INFARCTION; ISCHEMIA; PRIORITY JOURNAL; REGENERATION; UPREGULATION;

HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY;

EID: 33750064859     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.064931     Document Type: Editorial

References (17)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation 1986;74: 1124-36.
2. Yellon DM, Dana A. The preconditioning phenomenon. A tool for the scientist or a clinical reality? Circulation Res 2000;87:543-50.
3. Ikonomidis JS, Tummiati LC, Weisel RD, et al. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia. Cardiovascular Res 1994;28:1285-91.
4. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-7.
5. Clavien PA, Selzener M, Rudiger HA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischaemic preconditioning. Ann Surg 2003;238:843-50.
6. Pasupathy S, Homer-Vanniasinkam S. Ischaemic preconditioning protects against ischaemia/reperfusion injury: emerging concepts. Eur J Vasc Endovasc Surgery 2005;29:106-15.
7. Tomai F, Crea F, Gaspardone A, et al. Molecular and cellular responses: ischaemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K Sup + channel blocker. Circulation 1994;90:700-5.
8. Yellon DM, Baxter GF. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? Heart 2000;83:381-7.
9. Mahaffey KW, Puma JA, Barbagelata NA, et al. Adenosine as an adjunct to thrombolytic therapy: results of a multicenter, randomized, placebo-controlled trial: the acute myocardial infarction study of adenosine (AMISTAD) trial. J Am Coll Cardiol 1999;34:1711-20.
10. Patel DJ, Purcell HJ, Fox KM. Cardioprotection by opening of the KATP channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomised study with nicorandil. Eur Heart J 1999;20:51-7.
11. Chen S, Li G, Long L. Clinical research of ischaemic preconditioning on lung protection. Hunan Yi Ked a Xue Xue Bao 1990;24:357-9.
12. Kharbanda RK, Li J, Konstantinov I, et al. Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study. Heart 2006;92:1506-11.
13. Gho BCG, Schoemaker RG, Van Den Doel MA, et al. Myocardial protection by brief ischaemia in non-cardiac tissue. Circulation 1996;94:2193-200.
14. Waldow T, Alexiou K, Witt W, et al. Protection against porcine lung ischaemia/reperfusion injury by systemic preconditioning via hind limb ischaemia. Transplant International 2005;18:198-205.
15. Kharbanda RK, Mortensen UM, White PA, et al. Transient limb iscahemia induces remote ischaemic preconditioning in vivo. Circulation 2002;106:2881-3.
16. Heusch G, Schulz R. Remote preconditioning. J Mol Cell Cardiol 2002;34:1279-81.
17. Pang CY, Addison P, Forrest CR, et al. Global protection against skeletal muscle infarction by non-invasive remote pre-conditioning. Circulation 2002;106(suppl II):133.